Psychiatric Hospitals Fail to Disclose FDA-Mandated Risks for Electroshock Therapy

What Happened

A review of over 50 psychiatric facilities across 23 states has uncovered a widespread failure to provide patients with mandatory safety disclosures regarding electroconvulsive therapy (ECT). Despite 2018 FDA requirements for updated risk warnings, none of the surveyed websites include necessary information about potential long-term cognitive side effects.

The Citizens Commission on Human Rights (CCHR) reports that patients are frequently not warned about risks such as permanent memory loss, cardiovascular complications, or their legal right to decline treatment. These omissions persist even as hospitals continue to promote the procedure for conditions the FDA has not cleared for such use.

The analysis highlights a significant gap between federal safety guidelines and clinical practice. While the FDA has mandated specific labeling regarding the lack of demonstrated long-term safety and efficacy, these warnings remain absent from patient-facing materials at the facilities investigated.

The Core Points

Over 50 psychiatric hospitals failed to update patient warnings to meet 2018 FDA standards.
88% of surveyed facilities did not inform patients of their legal right to refuse treatment.
Majority of hospitals promote ECT for conditions lacking FDA-cleared safety data.
Data indicates ECT patients face longer hospital stays and significantly higher costs than standard care.
Expert testimony and court rulings have linked the procedure to permanent cognitive impairment.

Context in 60 Seconds

The ECT industry has grown into a multi-billion dollar sector, yet it remains under heavy scrutiny due to concerns over oversight and the lack of clinical trials supporting its safety for various psychiatric conditions. Many devices used today were grandfathered in decades ago without modern premarket approval, leading to ongoing debates about the necessity of the procedure and the validity of current administrative regulations.

Societal concern is mounting as critics compare the practice to physical trauma, citing court-upheld testimony regarding persistent brain damage. With state laws governing ECT remaining inconsistent—and in many cases, non-existent for minor patients—advocacy groups are intensifying calls for stricter judicial oversight and potential bans on the use of these devices.

Bottom Line

Widespread failure to disclose essential safety risks for ECT exposes a critical gap in patient informed consent and regulatory enforcement within the psychiatric industry.

Loading briefing details...